19-7630627-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001171155.2(PET100):​c.82G>A​(p.Glu28Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000761 in 1,537,182 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 10/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E28Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0037 ( 7 hom., cov: 32)
Exomes 𝑓: 0.00044 ( 3 hom. )

Consequence

PET100
NM_001171155.2 missense

Scores

2
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 2.49

Publications

6 publications found
Variant links:
Genes affected
PET100 (HGNC:40038): (PET100 cytochrome c oxidase chaperone) Mitochondrial complex IV, or cytochrome c oxidase, is a large transmembrane protein complex that is part of the respiratory electron transport chain of mitochondria. The small protein encoded by this gene plays a role in the biogenesis of mitochondrial complex IV. This protein localizes to the inner mitochondrial membrane and is exposed to the intermembrane space. Mutations in this gene are associated with mitochondrial complex IV deficiency. This gene has a pseudogene on chromosome 3. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014]
STXBP2 (HGNC:11445): (syntaxin binding protein 2) This gene encodes a member of the STXBP/unc-18/SEC1 family. The encoded protein is involved in intracellular trafficking, control of SNARE (soluble NSF attachment protein receptor) complex assembly, and the release of cytotoxic granules by natural killer cells. Mutations in this gene are associated with familial hemophagocytic lymphohistiocytosis. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2013]
STXBP2 Gene-Disease associations (from GenCC):
  • familial hemophagocytic lymphohistiocytosis 5
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • hereditary hemophagocytic lymphohistiocytosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • microvillus inclusion disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0075425804).
BP6
Variant 19-7630627-G-A is Benign according to our data. Variant chr19-7630627-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 235437.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00368 (561/152256) while in subpopulation AFR AF = 0.0126 (522/41526). AF 95% confidence interval is 0.0117. There are 7 homozygotes in GnomAd4. There are 266 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PET100NM_001171155.2 linkc.82G>A p.Glu28Lys missense_variant Exon 2 of 4 ENST00000594797.6 NP_001164626.1 P0DJ07
PET100NR_033242.2 linkn.123G>A non_coding_transcript_exon_variant Exon 2 of 5
STXBP2NM_001414484.1 linkc.-116G>A 5_prime_UTR_variant Exon 2 of 21 NP_001401413.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PET100ENST00000594797.6 linkc.82G>A p.Glu28Lys missense_variant Exon 2 of 4 1 NM_001171155.2 ENSP00000470539.1 P0DJ07
ENSG00000268400ENST00000698368.1 linkn.82G>A non_coding_transcript_exon_variant Exon 2 of 20 ENSP00000513686.1 A0A8V8TM65

Frequencies

GnomAD3 genomes
AF:
0.00365
AC:
555
AN:
152138
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0125
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00164
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00107
AC:
152
AN:
142022
AF XY:
0.000763
show subpopulations
Gnomad AFR exome
AF:
0.0151
Gnomad AMR exome
AF:
0.000732
Gnomad ASJ exome
AF:
0.00131
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000106
Gnomad OTH exome
AF:
0.000469
GnomAD4 exome
AF:
0.000440
AC:
609
AN:
1384926
Hom.:
3
Cov.:
31
AF XY:
0.000399
AC XY:
273
AN XY:
683394
show subpopulations
African (AFR)
AF:
0.0140
AC:
442
AN:
31590
American (AMR)
AF:
0.000952
AC:
34
AN:
35700
Ashkenazi Jewish (ASJ)
AF:
0.000913
AC:
23
AN:
25182
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35734
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79234
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
35016
Middle Eastern (MID)
AF:
0.00140
AC:
8
AN:
5696
European-Non Finnish (NFE)
AF:
0.0000510
AC:
55
AN:
1078858
Other (OTH)
AF:
0.000812
AC:
47
AN:
57916
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
31
63
94
126
157
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00368
AC:
561
AN:
152256
Hom.:
7
Cov.:
32
AF XY:
0.00357
AC XY:
266
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.0126
AC:
522
AN:
41526
American (AMR)
AF:
0.00163
AC:
25
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68028
Other (OTH)
AF:
0.00189
AC:
4
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
31
62
94
125
156
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00132
Hom.:
3
Bravo
AF:
0.00396
ESP6500AA
AF:
0.0145
AC:
20
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00154
AC:
37
Asia WGS
AF:
0.00202
AC:
7
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
May 08, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Apr 25, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Sep 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PET100: BP4, BS1, BS2 -

Dec 09, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

PET100-related disorder Benign:1
Jul 12, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.45
CADD
Uncertain
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.067
T;.
Eigen
Benign
-0.25
Eigen_PC
Benign
-0.14
FATHMM_MKL
Benign
0.66
D
LIST_S2
Benign
0.82
T;T
MetaRNN
Benign
0.0075
T;T
MetaSVM
Benign
-0.97
T
PhyloP100
2.5
PrimateAI
Benign
0.41
T
Sift4G
Uncertain
0.053
T;D
Polyphen
0.0030
B;.
Vest4
0.21
MVP
0.061
ClinPred
0.044
T
GERP RS
1.9
Varity_R
0.23
gMVP
0.90
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4134804; hg19: chr19-7695513; COSMIC: COSV60697211; COSMIC: COSV60697211; API